APO RESEARCH · REPORT
Large Volume Parenteral (LVP)
Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
Product & engineering
Understand the product.
Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
Selected research
Industry Research
Large Volume Parenteral (LVP) Industry Research Report 2026
Market perspective
Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.
Report Scope
Read the full market overview
This report quantifies the global Large Volume Parenteral (LVP) market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Large Volume Parenteral (LVP) Market by Company
Baxter Healthcare
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
CR Double-Crane
Pisa
Huaren
Patheon
Beximco Pharma
Albert David
PSI Ltd
Ozon Pharmaceuticals
BAG Healthcare
BML Parenteral Drugs
Large Volume Parenteral (LVP) Segment by Type
Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP
Large Volume Parenteral (LVP) Segment by Application
Basic Infusion
Therapeutic Infusion
Nutritious Infusion
Large Volume Parenteral (LVP) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large Volume Parenteral (LVP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Large Volume Parenteral (LVP) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large Volume Parenteral (LVP).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Large Volume Parenteral (LVP) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Large Volume Parenteral (LVP) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Large Volume Parenteral (LVP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Soft Bag LVP
- Plastic Bottle LVP
- Glass Bottle LVP
Applications
- Basic Infusion
- Therapeutic Infusion
- Nutritious Infusion
Companies covered
- Baxter Healthcare
- Kelun Pharma
- B. Braun
- Fresenius
- Teva Pharmaceutical Industries
- Pfizer (Hospira)
- Ostuka Pharmaceutical
- CR Double-Crane
- Pisa
- Huaren
- Patheon
- Beximco Pharma
- Albert David
- PSI Ltd
- Ozon Pharmaceuticals
- BAG Healthcare
- BML Parenteral Drugs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Large Volume Parenteral (LVP) Market Size (2021-2032)
- 2.2.2 Global Large Volume Parenteral (LVP) Sales (2021-2032)
- 2.2.3 Global Large Volume Parenteral (LVP) Market Average Price (2021-2032)
- 2.3 Large Volume Parenteral (LVP) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Soft Bag LVP
- 2.3.3 Plastic Bottle LVP
- 2.3.4 Glass Bottle LVP
- 2.4 Large Volume Parenteral (LVP) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Basic Infusion
- 2.4.3 Therapeutic Infusion
- 2.4.4 Nutritious Infusion
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Large Volume Parenteral (LVP) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Large Volume Parenteral (LVP) Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Large Volume Parenteral (LVP) Revenue of Manufacturers (2021-2026)
- 3.4 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2021-2026)
- 3.5 Global Large Volume Parenteral (LVP) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Large Volume Parenteral (LVP), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Large Volume Parenteral (LVP), Product Type & Application
- 3.8 Global Manufacturers of Large Volume Parenteral (LVP), Established Date
- 3.9 Global Large Volume Parenteral (LVP) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Baxter Healthcare
- 4.1.1 Baxter Healthcare Company Information
- 4.1.2 Baxter Healthcare Business Overview
- 4.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
- 4.1.5 Baxter Healthcare Recent Developments
- 4.2 Kelun Pharma
- 4.2.1 Kelun Pharma Company Information
- 4.2.2 Kelun Pharma Business Overview
- 4.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
- 4.2.5 Kelun Pharma Recent Developments
- 4.3 B. Braun
- 4.3.1 B. Braun Company Information
- 4.3.2 B. Braun Business Overview
- 4.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
- 4.3.5 B. Braun Recent Developments
- 4.4 Fresenius
- 4.4.1 Fresenius Company Information
- 4.4.2 Fresenius Business Overview
- 4.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
- 4.4.5 Fresenius Recent Developments
- 4.5 Teva Pharmaceutical Industries
- 4.5.1 Teva Pharmaceutical Industries Company Information
- 4.5.2 Teva Pharmaceutical Industries Business Overview
- 4.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
- 4.5.5 Teva Pharmaceutical Industries Recent Developments
- 4.6 Pfizer (Hospira)
- 4.6.1 Pfizer (Hospira) Company Information
- 4.6.2 Pfizer (Hospira) Business Overview
- 4.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
- 4.6.5 Pfizer (Hospira) Recent Developments
- 4.7 Ostuka Pharmaceutical
- 4.7.1 Ostuka Pharmaceutical Company Information
- 4.7.2 Ostuka Pharmaceutical Business Overview
- 4.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
- 4.7.5 Ostuka Pharmaceutical Recent Developments
- 4.8 CR Double-Crane
- 4.8.1 CR Double-Crane Company Information
- 4.8.2 CR Double-Crane Business Overview
- 4.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
- 4.8.5 CR Double-Crane Recent Developments
- 4.9 Pisa
- 4.9.1 Pisa Company Information
- 4.9.2 Pisa Business Overview
- 4.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pisa Large Volume Parenteral (LVP) Product Portfolio
- 4.9.5 Pisa Recent Developments
- 4.10 Huaren
- 4.10.1 Huaren Company Information
- 4.10.2 Huaren Business Overview
- 4.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Huaren Large Volume Parenteral (LVP) Product Portfolio
- 4.10.5 Huaren Recent Developments
- 4.11 Patheon
- 4.11.1 Patheon Company Information
- 4.11.2 Patheon Business Overview
- 4.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Patheon Large Volume Parenteral (LVP) Product Portfolio
- 4.11.5 Patheon Recent Developments
- 4.12 Beximco Pharma
- 4.12.1 Beximco Pharma Company Information
- 4.12.2 Beximco Pharma Business Overview
- 4.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
- 4.12.5 Beximco Pharma Recent Developments
- 4.13 Albert David
- 4.13.1 Albert David Company Information
- 4.13.2 Albert David Business Overview
- 4.13.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
- 4.13.5 Albert David Recent Developments
- 4.14 PSI Ltd
- 4.14.1 PSI Ltd Company Information
- 4.14.2 PSI Ltd Business Overview
- 4.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
- 4.14.5 PSI Ltd Recent Developments
- 4.15 Ozon Pharmaceuticals
- 4.15.1 Ozon Pharmaceuticals Company Information
- 4.15.2 Ozon Pharmaceuticals Business Overview
- 4.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
- 4.15.5 Ozon Pharmaceuticals Recent Developments
- 4.16 BAG Healthcare
- 4.16.1 BAG Healthcare Company Information
- 4.16.2 BAG Healthcare Business Overview
- 4.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
- 4.16.5 BAG Healthcare Recent Developments
- 4.17 BML Parenteral Drugs
- 4.17.1 BML Parenteral Drugs Company Information
- 4.17.2 BML Parenteral Drugs Business Overview
- 4.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
- 4.17.5 BML Parenteral Drugs Recent Developments
5 Global Large Volume Parenteral (LVP) Market Scenario by Region
- 5.1 Global Large Volume Parenteral (LVP) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Large Volume Parenteral (LVP) Sales by Region: 2021-2032
- 5.2.1 Global Large Volume Parenteral (LVP) Sales by Region: 2021-2026
- 5.2.2 Global Large Volume Parenteral (LVP) Sales by Region: 2027-2032
- 5.3 Global Large Volume Parenteral (LVP) Revenue by Region: 2021-2032
- 5.3.1 Global Large Volume Parenteral (LVP) Revenue by Region: 2021-2026
- 5.3.2 Global Large Volume Parenteral (LVP) Revenue by Region: 2027-2032
- 5.4 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
- 5.4.1 North America Large Volume Parenteral (LVP) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Large Volume Parenteral (LVP) Sales by Country (2021-2032)
- 5.4.3 North America Large Volume Parenteral (LVP) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
- 5.5.1 Europe Large Volume Parenteral (LVP) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Large Volume Parenteral (LVP) Sales by Country (2021-2032)
- 5.5.3 Europe Large Volume Parenteral (LVP) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Large Volume Parenteral (LVP) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Large Volume Parenteral (LVP) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Large Volume Parenteral (LVP) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Large Volume Parenteral (LVP) Market Facts & Figures by Country
- 5.7.1 South America Large Volume Parenteral (LVP) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Large Volume Parenteral (LVP) Sales by Country (2021-2032)
- 5.7.3 South America Large Volume Parenteral (LVP) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Large Volume Parenteral (LVP) Sales by Type (2021-2032)
- 6.1.1 Global Large Volume Parenteral (LVP) Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2021-2032)
- 6.2 Global Large Volume Parenteral (LVP) Revenue by Type (2021-2032)
- 6.2.1 Global Large Volume Parenteral (LVP) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2021-2032)
- 6.3 Global Large Volume Parenteral (LVP) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Large Volume Parenteral (LVP) Sales by Application (2021-2032)
- 7.1.1 Global Large Volume Parenteral (LVP) Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2021-2032)
- 7.2 Global Large Volume Parenteral (LVP) Revenue by Application (2021-2032)
- 7.2.1 Global Large Volume Parenteral (LVP) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2021-2032)
- 7.3 Global Large Volume Parenteral (LVP) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Large Volume Parenteral (LVP) Value Chain Analysis
- 8.1.1 Large Volume Parenteral (LVP) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Large Volume Parenteral (LVP) Production Mode & Process
- 8.2 Large Volume Parenteral (LVP) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Large Volume Parenteral (LVP) Distributors
- 8.2.3 Large Volume Parenteral (LVP) Customers
9 Global Large Volume Parenteral (LVP) Analyzing Market Dynamics
- 9.1 Large Volume Parenteral (LVP) Industry Trends
- 9.2 Large Volume Parenteral (LVP) Industry Drivers
- 9.3 Large Volume Parenteral (LVP) Industry Opportunities and Challenges
- 9.4 Large Volume Parenteral (LVP) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst